Literature DB >> 15897972

Mass screening of prostate cancer in a Chinese population: the relationship between pathological features of prostate cancer and serum prostate specific antigen.

Hong-Wen Gao1, Yu-Lin Li, Shan Wu, Yi-Shu Wang, Hai-Feng Zhang, Yu-Zhuo Pan, Ling Zhang, Hiroo Tateno, Ikuro Sato, Masaaki Kuwahara, Xue-Jian Zhao.   

Abstract

AIM: To investigate the pathological features of the prostate biopsy through mass screening for prostate cancer in a Chinese cohort and their association with serum prostate specific antigen (PSA).
METHODS: A total of 12027 Chinese men in Changchun were screened for prostate cancer by means of the serum total prostate specific antigen tPSA test (by Elisa assay). Transrectal ultrasound-guided systematic six-sextant biopsies were performed on those whose serum tPSA value was > 4.0 ng/mL and those who had obstructive symptoms (despite their tPSA value) and were subject to subsequent pathological analysis with the aid of the statistic software SPSS 10.0 (SPSS. Inc., Chicago. USA).
RESULTS: Of the 12027 cases, 158 (including 137 patients whose serum tPSA values were 4.0 ng/mL and 21 patients [serum tPSA < 4.0 ng/mL] who had obstructive symptoms) undertook prostate biopsy. Of the 158 biopsies, 41 cases of prostatic carcinoma were found (25.9 %, 41/158). The moderately differentiated carcinoma and poorly differentiated carcinoma accounted for 61% and 34%, respectively. A significant linear positive correlation between the serum tPSA and the Gleason scores in the 41 cases of prostatic carcinoma (r = 0.312, P < 0.01) was established. A significant linear positive correlation between the serum tPSA value of the 41 prostatic carcinoma and the positive counts of carcinoma in sextant biopsies was established (r = 0.406, P < 0.01), indicating a significant linear relationship between serum tPSA and the size of tumor.
CONCLUSION: This study was the first to conduct mass screening for prostate cancer by testing for serum tPSA values and the first to investigate the pathological features of prostate cancer in a cohort of Chinese men. Our results reveal that the moderately differentiated carcinoma is the most common type of prostate cancer. This study also has shown that the serum tPSA value in prostate cancer is associated with the Gleason score and the size of tumor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15897972     DOI: 10.1111/j.1745-7262.2005.00029.x

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  10 in total

Review 1.  Prostate cancer: an emerging threat to the health of aging men in Asia.

Authors:  Ling Zhang; Bao-Xue Yang; Hai-Tao Zhang; Jin-Guo Wang; Hong-Liang Wang; Xue-Jian Zhao
Journal:  Asian J Androl       Date:  2011-05-09       Impact factor: 3.285

2.  The value of prostate-specific antigen in Asia.

Authors:  Chaidir Arif Mochtar; R Siddhi Andika
Journal:  Ther Adv Urol       Date:  2010-04

Review 3.  Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China.

Authors:  Ling Zhang; Shan Wu; Li-Rong Guo; Xue-Jian Zhao
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

4.  Prostate-specific antigen screening for prostate cancer: benefits for patients with highly aggressive prostate cancer.

Authors:  Hui-Jie Jia; Yang Li; Jin-Guo Wang; Ling Zhang; Hai-Tao Zhang; Xue-Jian Zhao; Masaaki Kuwahara
Journal:  Asian J Androl       Date:  2013-01-21       Impact factor: 3.285

5.  Clinical and pathological characteristics of screen-detected versus clinically diagnosed prostate cancer in Nanjing, China.

Authors:  LiXin Hua; Di Qiao; Bin Xu; NingHan Feng; Gong Cheng; JieXiu Zhang; NingHong Song; Wei Zhang; Jie Yang; JianGang Chen; YuanGeng Sui; HongFei Wu
Journal:  Med Oncol       Date:  2010-01-14       Impact factor: 3.064

6.  External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort.

Authors:  Yao Zhu; Jin-You Wang; Yi-Jun Shen; Bo Dai; Chun-Guang Ma; Wen-Jun Xiao; Guo-Wen Lin; Xu-Dong Yao; Shi-Lin Zhang; Ding-Wei Ye
Journal:  Asian J Androl       Date:  2012-05-07       Impact factor: 3.285

7.  Antiprostate Cancer Activity of Ineupatolide Isolated from Carpesium cernuum L.

Authors:  Yuan-She Huang; Jing-Xin Mao; Lai Zhang; Hong-Wei Guo; Chen Yan; Min Chen
Journal:  Biomed Res Int       Date:  2021-04-29       Impact factor: 3.411

8.  Prostate cancer detection upon transrectal ultrasound-guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chinese population?

Authors:  Jeremy Yc Teoh; Steffi Kk Yuen; James Hl Tsu; Charles Kw Wong; Brian Sh Ho; Ada Tl Ng; Wai-Kit Ma; Kwan-Lun Ho; Ming-Kwong Yiu
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

9.  Incidental detection of prostate-specific antigen-negative metastatic prostate cancer initially presented with solitary pulmonary nodule on fluorodeoxyglucose positron emission tomography/computed tomography.

Authors:  Ezgi Basak Erdogan; Nur Buyukpinarbasili; Sedat Ziyade; Tolga Akman; Haci Mehmet Turk; Mehmet Aydin
Journal:  Indian J Nucl Med       Date:  2015 Jul-Sep

Review 10.  Prostate cancer screening in Europe and Asia.

Authors:  Kai Zhang; Chris H Bangma; Monique J Roobol
Journal:  Asian J Urol       Date:  2016-09-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.